{"name":"Provectus Pharmaceuticals","slug":"provectus-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":1897276,"netIncome":-5430851,"cash":251291,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2015"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"Bolsamania","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Bolsamania","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"date":"2026-02-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOSTB2MDBQdVVMZ0hIa3R6VlpHek1CSWpJMzRPeXMtVFMzS056WUxWM1J2Ml9abmY0SjVmY0ZvZ3RqRkhvT1kyWmcwNndJd2Rld3BpNHhveGpLXzJvQk41Vl9lODdZZEUwdXBCenJnNTlhcEhxRlBMQnlEWWNsSzc0Nm9ETGE5T1Ez?oc=5","date":"2024-10-31","type":"earnings","source":"Statista","summary":"Revenue of Provectus Biopharmaceuticals from 2014 to 2024 - Statista","headline":"Revenue of Provectus Biopharmaceuticals from 2014 to 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxOTDJFUEpqQ0dhcUhfUFh0VUpVTU1YZ1cyVXZZX2V5TmFyRmhHUFA0MXhJUFFtazluUjRYTmR6dG5iMk5vSl85VmVvRnVTT0YxQXd0TWlPcnE0bHk3eDhEa2g4Qng0dEJMZDdJU2ltaDBCMlJLdnpXN004RTh2bnJ0cUZEQnNiQ09zVHJqRG9JTTZCZlBhOWlLME9IWXJZNWtlbm9IQzczbGtyR1dDZGgyRXpGOFRibVZPWGp6U2NuMlhKWU51bXpGWEJiYw?oc=5","date":"2024-05-20","type":"pipeline","source":"Knoxville News Sentinel","summary":"'Called to shepherd': PYA's Ed Pershing gets second career as Provectus CEO - Knoxville News Sentinel","headline":"'Called to shepherd': PYA's Ed Pershing gets second career as Provectus CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOZzdtbXN0Wl83RzVTMVBvVzVpV25la1loQTh5dVFxQzBhaXFpV2xiT0NBNjF6aEs0cDA1R0JKVTZadjd3ZFpKSk16aXNjbXRaWHhZV1k3Q3JBOVFEVWpkZWtfWmVUdFRTNERUdm1NdFk5QmZnaTVWR0JsQ0RaTzQxeFg4VEc4X2QtRnNmVDJkTktwblhBVVZGZ1pteTBzdw?oc=5","date":"2023-09-14","type":"deal","source":"Pharmafile","summary":"Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India - Pharmafile","headline":"Sun Pharma and Pharmazz enter license agreement for Tyvalzi in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQeDNrbnMxWXlZcmUzaTVubGlDZ1R6SHNxbzdkSmNYWlJYTzl5ZjdCdHBEamxZWktESTlvdW5wTXNIMVRCVXozTXpILXdGV2VsQng3bnNwaUJTbzdqZlg5RzE5YzBmRkNpNzVWYzIybzFYdjhpNDlfZDZ4Tk1ZOENVdUdBb2t0bDlWdHVz?oc=5","date":"2016-12-29","type":"pipeline","source":"BioSpace","summary":"Provectus Fires Peter Culpepper as Interim CEO and COO - BioSpace","headline":"Provectus Fires Peter Culpepper as Interim CEO and COO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2015-12-31","revenueHistory":[{"value":0,"period":"2015-12-31"},{"value":0,"period":"2014-12-31"},{"value":0,"period":"2013-12-31"},{"value":0,"period":"2012-12-31"}],"grossProfit":24541,"grossProfitHistory":[],"rdSpend":1897276,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5430851,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":251291,"cashHistory":[],"totalAssets":697502,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}